Cargando…

Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?

Nonalcoholic fatty liver disease (NAFLD) is associated with systemic changes in immune response linked with chronic low-grade inflammation and disease progression. Semaphorins, a large family of biological response modifiers, were recently recognized as one of the key regulators of immune responses,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Šamadan, Lara, Papić, Neven, Mijić, Maja, Knežević Štromar, Ivana, Gašparov, Slavko, Vince, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775767/ https://www.ncbi.nlm.nih.gov/pubmed/36551769 http://dx.doi.org/10.3390/biomedicines10123014

Ejemplares similares

1347. Do Class 3 Semaphorins Play a Role in COVID-19 Outcomes in Patients with Non-alcoholic Fatty Liver Disease?
por: Vargovic, Martina, et al.
Publicado: (2023)

The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C
por: Papic, Neven, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection
por: Šamadan, Lara, et al.
Publicado: (2021)

Association of Immune Semaphorins with COVID-19 Severity and Outcomes
por: Vargovic, Martina, et al.
Publicado: (2023)

Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
por: Vrsaljko, Nina, et al.
Publicado: (2022)

Unresolved issues in hepatitis C: The role of liver non-parenchymal cells and semaphorins
por: Vince, Adriana, et al.
Publicado: (2018)

311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19
por: Vrsaljko, Nina, et al.
Publicado: (2021)

Distinct Cytokine Profiles in Severe COVID-19 and Non-Alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
por: Virović Jukić, Lucija, et al.
Publicado: (2021)

The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes
por: Gjurašin, Branimir, et al.
Publicado: (2022)

Intravenous Drug Users Can Achieve a High Sustained Virological Response Rate: experience From Croatian Reference Center for Viral Hepatitis
por: Kurelac, Ivan, et al.
Publicado: (2011)

Endovascular treatment of an obstructive membrane between inferior vena cava and right atrium in an unrecognized Budd-Chiari syndrome
por: Strozzi, Maja, et al.
Publicado: (2020)

External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis
por: Gazda, Jakub, et al.
Publicado: (2021)

145. Liver Steatosis as a Risk Factor for Invasive Group B Streptococcus Infection in Non-Pregnant Adults
por: Papic, Neven, et al.
Publicado: (2019)

COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
por: Močibob, Loris, et al.
Publicado: (2022)

Clinical and Laboratoy Characteristics of Parvovirus B19 Infection During 2013/2014 Outbreak in Zagreb, Croatia
por: Ajdukovic, Mia, et al.
Publicado: (2017)

Systemic Cat Scratch Disease in Immunocompetent Adults: A Retrospective Case Series
por: Gjurasin, Branimir, et al.
Publicado: (2017)

TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
por: Susak, Frano, et al.
Publicado: (2023)

299. Distinct TGF-β1 Patterns in Patients with Sepsis and Non-alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2023)

2411. One Dose Vancomycin Prophylaxis for In-Hospital Clostridioides difficile - Associated Disease
por: Papic, Neven, et al.
Publicado: (2019)

Semaphorin 7A plays a critical role in TGF-β(1)–induced pulmonary fibrosis
por: Kang, Hye-Ryun, et al.
Publicado: (2007)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2020)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Liver involvement during influenza infection: perspective on the 2009 influenza pandemic
por: Papic, Neven, et al.
Publicado: (2011)

Retroperitoneal Paraganglioma Treated With Tumor Resection and Replacement of the Inferior Vena Cava
por: Đapić, Krešimir, et al.
Publicado: (2023)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022)

Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia
por: Papic, Neven, et al.
Publicado: (2020)

Treatment of Elderly Patients with Chronic Hepatitis C: A Retrospective Cohort Study
por: Papić, Neven, et al.
Publicado: (2018)

Human Alveolar Echinococcosis, Croatia
por: Dušek, Davorka, et al.
Publicado: (2020)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
por: Małecki, Paweł, et al.
Publicado: (2020)

Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis
por: Carvalheiro, Tiago, et al.
Publicado: (2019)

Treatment of chronic hepatitis C in Croatian war veterans: experiences from Croatian reference center for viral hepatitis
por: Papić, Neven, et al.
Publicado: (2011)

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
por: Nascimbeni, Fabio, et al.
Publicado: (2018)

The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Almeda-Valdes, Paloma, et al.
Publicado: (2015)

Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Nakano, Masakazu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g1d03hfc070932q9to9vqboplk